An Annual Multi-Cancer Screening Test

Early detection of cancer is vital for successful treatment and cure. Late detection invariably leads to intensive and toxic treatments, high treatment costs and treatment failure. Trucheck™ is a revolutionary test, based on a simple blood draw, for early detection of multiple types of cancer to help secure you and your family's future.

See Our Latest Press Release

Slider Image
Slider Image

An Annual Multi-Cancer Screening Test

Early detection of cancer is vital for successful treatment and cure. Late detection invariably leads to intensive and toxic treatments, high treatment costs and treatment failure. Trucheck™ is a revolutionary test, based on a simple blood draw, for early detection of multiple types of cancer to help secure you and your family's future.

See Our Latest Press Release

Advantages of Trucheck™?

Slider Image

Being a non-invasive blood-based test, Trucheck™ can minimize the need to visit a healthcare centre – since the blood sample can also be collected from the privacy and comfort of your home.

Advantages to the individuals:

  1. Wait times for appointments are reduced
  2. Minimized risk of COVID exposure
  3. May be assimilated into annual health check-up
  4. No risk of radiation or those associated with invasive procedures

Advantages to the system:

  1. Reduces risk of COVID transmission and exposure of staff
  2. Reductions in avoidable / non-critical appointments
  3. Minimizes procedures that may be retrospectively deemed unnecessary
  4. Supports decision making in conjunction with existing tests / methods

Trucheck™ - Intelli can Detect 70+ Types of Cancers

Melanoma, Head and Neck, Salivary Gland, Thyroid, Lung, Breast, Liver, Biliary Tract, Gastro-Intestinal, Soft Tissue and Osteosarcomas, Mesothelioma, Urinary Tract, Gynaecological, Male Cancers including Prostate, CNS, Thymus, Adrenal, Skin.

Why should I consider Trucheck™?

Circulating Tumor Cells (CTCs) and their clusters are present in the blood of almost all cancer patients and are undetectable even in seemingly healthy individuals.
Trucheck™ technology to detect and characterise CTCs has been proven through extensive clinical validations involving more than 40,000 participants. The test is a paradigm shift in cancer screening, as it does not involve radiation or invasive procedures. The test is performed at our world-class laboratory, which meets and exceeds all national and international standards.
Slider Image

Illustrative Images of CTCs


Lung
Napsin-A, TTF-1, p40
Slider Image

Trucheck™ is Accurate


The Development of Trucheck™ includes extensive Analytical and Clinical validation studies to establish its Accuracy and Reliability.

Trucheck™ has been clinically proven to have accuracy of > 99% in detecting cancer early. Trucheck™ has high accuracy to localize the tissue of origin.

For Patients

Ask Your Doctor


Our patient's downloadable content has all the information you and your doctor need to discuss Trucheck™ testing.